Little EC - Search Results

1

The inducible costimulator augments Tc17 cell responses to self and tumor tissue.

Nelson MH, Kundimi S, Bowers JS, Rogers CE, Huff LW, Schwartz KM, Thyagarajan K, Little EC, Mehrotra S, Cole DJ, Rubinstein MP, Paulos CM. Nelson MH, et al. Among authors: little ec. J Immunol. 2015 Feb 15;194(4):1737-47. doi: 10.4049/jimmunol.1401082. Epub 2015 Jan 9. J Immunol. 2015. PMID: 25576595 Free PMC article.

2

Novel immunocompetent murine models representing advanced local and metastatic pancreatic cancer.

Little EC, Wang C, Watson PM, Watson DK, Cole DJ, Camp ER. Little EC, et al. J Surg Res. 2012 Aug;176(2):359-66. doi: 10.1016/j.jss.2011.10.025. Epub 2011 Nov 10. J Surg Res. 2012. PMID: 22221605 Free PMC article.

3

The CaSm (LSm1) oncogene promotes transformation, chemoresistance and metastasis of pancreatic cancer cells.

Little EC, Camp ER, Wang C, Watson PM, Watson DK, Cole DJ. Little EC, et al. Oncogenesis. 2016 Jan 11;5(1):e182. doi: 10.1038/oncsis.2015.45. Oncogenesis. 2016. PMID: 26751936 Free PMC article.

4

Transferrin receptor targeting nanomedicine delivering wild-type p53 gene sensitizes pancreatic cancer to gemcitabine therapy.

Camp ER, Wang C, Little EC, Watson PM, Pirollo KF, Rait A, Cole DJ, Chang EH, Watson DK. Camp ER, et al. Among authors: little ec. Cancer Gene Ther. 2013 Apr;20(4):222-8. doi: 10.1038/cgt.2013.9. Epub 2013 Mar 8. Cancer Gene Ther. 2013. PMID: 23470564 Free PMC article.

5

Targeting Pan-ETS Factors Inhibits Melanoma Progression.

Huang L, Zhai Y, La J, Lui JW, Moore SPG, Little EC, Xiao S, Haresi AJ, Brem C, Bhawan J, Lang D. Huang L, et al. Among authors: little ec. Cancer Res. 2021 Apr 15;81(8):2071-2085. doi: 10.1158/0008-5472.CAN-19-1668. Epub 2021 Feb 1. Cancer Res. 2021. PMID: 33526511 Free PMC article.

6

The Efficiency of Verteporfin as a Therapeutic Option in Pre-Clinical Models of Melanoma.

Lui JW, Xiao S, Ogomori K, Hammarstedt JE, Little EC, Lang D. Lui JW, et al. Among authors: little ec. J Cancer. 2019 Jan 1;10(1):1-10. doi: 10.7150/jca.27472. eCollection 2019. J Cancer. 2019. PMID: 30662519 Free PMC article.

7

PAX3 and FOXD3 Promote CXCR4 Expression in Melanoma.

Kubic JD, Lui JW, Little EC, Ludvik AE, Konda S, Salgia R, Aplin AE, Lang D. Kubic JD, et al. Among authors: little ec. J Biol Chem. 2015 Sep 4;290(36):21901-14. doi: 10.1074/jbc.M115.670976. Epub 2015 Jul 23. J Biol Chem. 2015. PMID: 26205821 Free PMC article.

8

FOXD3 Promotes PAX3 Expression in Melanoma Cells.

Kubic JD, Little EC, Kaiser RS, Young KP, Lang D. Kubic JD, et al. Among authors: little ec. J Cell Biochem. 2016 Feb;117(2):533-41. doi: 10.1002/jcb.25306. Epub 2015 Sep 1. J Cell Biochem. 2016. PMID: 26252164 Free PMC article.

9

PAX3 and ETS1 synergistically activate MET expression in melanoma cells.

Kubic JD, Little EC, Lui JW, Iizuka T, Lang D. Kubic JD, et al. Among authors: little ec. Oncogene. 2015 Sep 17;34(38):4964-74. doi: 10.1038/onc.2014.420. Epub 2014 Dec 22. Oncogene. 2015. PMID: 25531327 Free PMC article.

10

Canonical and alternative transcript expression of PAX6 and CXCR4 in pancreatic cancer.

Little EC, Kubic JD, Salgia R, Grippo PJ, Lang D. Little EC, et al. Oncol Lett. 2017 Jun;13(6):4027-4034. doi: 10.3892/ol.2017.5956. Epub 2017 Mar 29. Oncol Lett. 2017. PMID: 28588695 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

25 results

Search Page